C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors

Pancreatic Neuroendocrine tumors (PanNET) are challenging to diagnose and often detected at advanced stages due to a lack of specific and sensitive biomarkers. This study utilized proteomics as a valuable approach for cancer biomarker discovery; therefore, mass spectrometry-based proteomic profiling...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorai, Priya Kumari, Bharti, Prahalad Singh, Kumar, Shashi, Rajacharya, Girish H., Bandyopadhyay, Sabyasachi, Pal, Sujoy, Dhingra, Renu, Kumar, Rakesh, Nikolajeff, Fredrik, Kumar, Saroj, Rani, Neerja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686980/
https://www.ncbi.nlm.nih.gov/pubmed/38030709
http://dx.doi.org/10.1038/s41598-023-48323-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686980/
https://www.ncbi.nlm.nih.gov/pubmed/38030709
http://dx.doi.org/10.1038/s41598-023-48323-x

Ejemplares similares